Oroszlány, Hungary

Zoltán Simon


 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zoltán Simon: Innovator in Pharmaceutical Compounds

Introduction

Zoltán Simon, a distinguished inventor based in Oroszlány, Hungary, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, he has focused his research on developing compounds that have the potential to revolutionize treatment options in the medical industry.

Latest Patents

Zoltán's latest inventions involve pharmaceutically effective compounds that selectively inhibit myosin 2 isoforms. The invention encompasses compounds of formula (I) or (II), including pharmaceutically acceptable salts, solvates, tautomers, stereoisomers, as well as enantiomers, diastereomers, and various mixtures of these compounds. These compounds possess promising pharmaceutical uses, indicating their potential in developing therapeutic agents.

Career Highlights

Throughout his career, Zoltán has collaborated with notable institutions, including Eötvös Loránd University and Printnet Kereskedelmi és Szolgáltató Kft. His work has been pivotal in advancing the understanding and application of myosin inhibitors, contributing to scientific knowledge and therapeutic advancements.

Collaborations

Zoltán has worked alongside esteemed colleagues, including András Málnási-Csizmadia and András Szabó. Their joint efforts in research and development have fortified the innovative process and led to significant findings in the pharmaceutical sector.

Conclusion

Zoltán Simon exemplifies the spirit of innovation within the pharmaceutical industry. His dedication to developing effective compounds highlights the importance of research in overcoming medical challenges. With his continued contributions, Zoltán is set to leave a lasting impact on healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…